Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-14 2:33 pm Purchase |
2022-12-31 | 13G | Amylyx Pharmaceuticals, Inc. AMLX |
PERCEPTIVE ADVISORS LLC | 6,088,333 9.200% |
3,116,920 (+104.90%) |
Filing History |
| 2023-02-14 2:33 pm Unchanged |
2022-12-31 | 13G | Tarsus Pharmaceuticals, Inc. TARS |
PERCEPTIVE ADVISORS LLC | 1,296,416 4.900% |
0 (Unchanged) |
Filing History |
| 2023-02-14 2:33 pm Sale |
2022-12-31 | 13G | IsoPlexis Corporation ISO |
PERCEPTIVE ADVISORS LLC | 4,095,498 10.000% |
-780,032 (-16.00%) |
Filing History |
| 2023-02-14 2:33 pm Unchanged |
2022-12-31 | 13G | Acrivon Therapeutics, Inc. Common Stock ACRV |
PERCEPTIVE ADVISORS LLC | 3,007,858 14.400% |
0 (Unchanged) |
Filing History |
| 2023-02-14 2:33 pm Sale |
2022-12-31 | 13G | IVERIC bio, Inc. ISEE |
PERCEPTIVE ADVISORS LLC | 587,400 0.400% |
-5,892,600 (-90.94%) |
Filing History |
| 2023-02-14 2:33 pm Purchase |
2022-12-31 | 13G | Aldeyra Therapeutics, Inc. ALDX |
PERCEPTIVE ADVISORS LLC | 11,350,085 19.400% |
1,446,206 (+14.60%) |
Filing History |
| 2023-02-14 2:32 pm Sale |
2022-12-31 | 13G | Iovance Biotherapeutics, Inc. IOVA |
PERCEPTIVE ADVISORS LLC | 9,971,780 6.300% |
-156,161 (-1.54%) |
Filing History |
| 2023-02-14 2:32 pm Purchase |
2022-12-31 | 13G | BELLUS Health Inc. BLU |
PERCEPTIVE ADVISORS LLC | 8,891,027 7.100% |
1,245,793 (+16.30%) |
Filing History |
| 2023-02-14 2:31 pm Purchase |
2022-12-31 | 13G | Zymeworks Inc. ZYME |
PERCEPTIVE ADVISORS LLC | 4,511,275 7.200% |
4,511,275 (New Position) |
Filing History |
| 2023-02-14 2:31 pm Sale |
2022-12-31 | 13G | enVVeno Medical Corporation NVNO |
PERCEPTIVE ADVISORS LLC | 937,515 9.900% |
-16,733 (-1.75%) |
Filing History |
| 2023-02-14 2:31 pm Purchase |
2022-12-31 | 13G | Amicus Therapeutics, Inc. FOLD |
PERCEPTIVE ADVISORS LLC | 27,642,917 9.800% |
286,874 (+1.05%) |
Filing History |
| 2023-02-14 2:31 pm Sale |
2022-12-31 | 13G | RAPT Therapeutics, Inc. RAPT |
PERCEPTIVE ADVISORS LLC | 1,798,955 5.300% |
-1,128,610 (-38.55%) |
Filing History |
| 2023-02-14 2:31 pm Purchase |
2022-12-31 | 13G | Arcellx, Inc. ACLX |
PERCEPTIVE ADVISORS LLC | 2,598,305 5.500% |
2,598,305 (New Position) |
Filing History |
| 2023-02-14 2:31 pm Sale |
2022-12-31 | 13G | ADMA Biologics, Inc. ADMA |
PERCEPTIVE ADVISORS LLC | 11,900,255 5.400% |
-33,132 (-0.28%) |
Filing History |
| 2023-02-14 2:31 pm Unchanged |
2022-12-31 | 13G | Agile Therapeutics, Inc. AGRX |
PERCEPTIVE ADVISORS LLC | 0 0.000% |
0 (Unchanged) |
Filing History |
| 2023-02-14 2:31 pm Sale |
2022-12-31 | 13G | Albireo Pharma, Inc. ALBO |
PERCEPTIVE ADVISORS LLC | 1,757,160 8.500% |
-602,979 (-25.55%) |
Filing History |
| 2023-02-14 2:31 pm Purchase |
2022-12-31 | 13G | Veru Inc. VERU |
PERCEPTIVE ADVISORS LLC | 7,858,011 9.700% |
7,858,011 (New Position) |
Filing History |
| 2023-02-14 2:31 pm Sale |
2022-12-31 | 13G | SpringWorks Therapeutics, Inc. SWTX |
PERCEPTIVE ADVISORS LLC | 2,617,691 4.200% |
-2,232,221 (-46.03%) |
Filing History |
| 2023-02-14 2:31 pm Sale |
2022-12-31 | 13G | Coherus BioSciences, Inc. CHRS |
PERCEPTIVE ADVISORS LLC | 0 0.000% |
-5,407,798 (Position Closed) |
Filing History |
| 2023-02-14 2:30 pm Sale |
2022-12-31 | 13G | Leap Therapeutics, Inc. LPTX |
PERCEPTIVE ADVISORS LLC | 672,650 6.800% |
-175,000 (-20.65%) |
Filing History |